title: Intraventricular neurocytomas.
abstract: The literature to date on the treatment of CNC reflects an evolution of clinical practice in neurooncology. The advent of sophisticated tools, such as MRS and molecular pathology, has facilitated more efficient diagnosis of CNC. Decreased morbidity associated with surgical intervention has resulted in better outcomes in patients undergoing resection of CNC. Prospective monitoring of treated patients with MRI coupled with judicious use of radiosurgery will likely further decrease treatment-related morbidity.
authors.affiliation: Department of Neurological Surgery, University of California at San Francisco, 505 Parnassus Avenue, M-779, San Francisco, CA 94143, USA.
authors.forename: Janet
authors.initials: J
authors.lastname: Lee
authors.forename: Susan M
authors.initials: SM
authors.lastname: Chang
authors.forename: Michael W
authors.initials: MW
authors.lastname: McDermott
authors.forename: Andrew T
authors.initials: AT
authors.lastname: Parsa
mesh_terms: D001921:Brain / Q000000981:diagnostic imaging / Q000473:pathology; D002551:Cerebral Ventricle Neoplasms / Q000175:diagnosis* / Q000378:metabolism / Q000601:surgery; D003937:Diagnosis, Differential; D006801:Humans; D007150:Immunohistochemistry; D008279:Magnetic Resonance Imaging; D018306:Neurocytoma / Q000175:diagnosis* / Q000378:metabolism / Q000601:surgery; D016708:Synaptophysin / Q000378:metabolism; D014057:Tomography, X-Ray Computed
chemical_list: D016708:Synaptophysin